Technology | August 10, 2011

FDA Clears Toshiba’s 3.0T MR

August 10, 2011 – In the 3.0 Tesla (T) magnetic resonance (MR) marketplace, patient compliance often impacts image quality and patient throughput. As the only 3.0T MR system designed to improve patient compliance and comfort while offering advanced radiology capabilities, Toshiba America Medical Systems Inc.’s new Vantage Titan 3.0T open-bore MR has received U.S. Food and Drug Administration (FDA) clearance. The new system is the only 3.0T MR offering patient-friendly features such as noise reduction, a wide and open bore, feet-first imaging and Toshiba’s proprietary contrast-free techniques.

By making MR exams more comfortable, patient compliance, exam efficiency and technologist productivity are improved. The Toshiba Vantage Titan 3.0T MR combines Toshiba’s commitment to patient comfort with the power of additional diagnostic capabilities.

Benefits of the Vantage Titan 3.0T open bore MR include:

1. Vantage Titan’s open bore offers a 71 cm aperture. The open bore’s larger diameter enables hospitals to scan bariatric patients with greater ease and provides patients with a greater feeling of openness to reduce claustrophobia.

2. Toshiba’s exclusive Pianissimo noise-reduction technology, which reduces exam noise by up to 90 percent, makes the Vantage Titan 3.0T MR the quietest available and solves one of the 3.0T  market’s greatest patient compliance issues. Since patients experience lower noise levels with Pianissimo, they stay more relaxed during exams and fewer motion artifacts are acquired, which helps improve image quality. Pianissimo also helps technologists image patients more successfully and reduces repeat exams.

3. Toshiba is the only imaging vendor to offer advanced contrast-free magnetic resonance angiography (MRA) techniques. Contrast-free MRA exams, including fresh blood imaging (FBI) for evaluating peripheral vascular diseases of the lower legs and extremities; contrast-free improved angiography (CIA) for easier visualization of smaller vessels; time-spatial labeling inversion pulse (Time-SLIP) for evaluating hemodynamic, functional assessments and visualization of vascular structures; and time space angiography (TSA) to create non-contrast time-resolved imaging with high temporal resolution.

4. The Vantage Titan 3.0T MR also utilizes Toshiba’s Atlas Speeder integrated coil technology to reduce exam time and improve the overall exam experience for patients.  Because the coils are integrated into the table, patients do not need to be continually repositioned for many exams, which saves time and improves patient comfort.

“From listening to our customers, we understand that patient compliance is one of the major issues impacting patient throughput and exam efficiency in the MR industry today,” said Stuart Clarkson, director, MR business unit, Toshiba. “Toshiba’s new Vantage Titan 3.0T MR is an example of our commitment to developing technology to meet our customers’ specific needs and enabling them to improve the exam experience, resulting in better patient compliance and throughput without sacrificing diagnostic confidence.”

For more information: www.medical.toshiba.com

Related Content

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.